
0.74 Delayed Data As of Dec 01 | ![]() Today’s Change | 0.65 Today|||52-Week Range 2.58 | -25.48% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $122.7M |
X4 Pharmaceuticals, Inc. 61 North Beacon Street Boston Massachusetts 02134 |
Paula S. Ragan | President, Chief Executive Officer & Director |
Mary DiBiase | Chief Operating Officer |
Adam S. Mostafa | Chief Financial Officer, Secretary & Treasurer |
Art Taveras | Chief Scientific Officer |
Christophe Arbet-Engels | Chief Medical Officer |